Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Saros Therapeutics Logo
Saros Therapeutics Growth Score
87
CB Rank
87521
Heat Score
66
Saros Therapeutics is working to enhance patients' response to immunotherapy.
Founded
obfuscation
PrivateGrant Chicago, Illinois, United States1-10 www.sarostx.com/
Biotechnology
Health Care
Life Science
Overview

Saros Therapeutics
Total Funding
obfuscation
Growth Score
87
Heat Score
66

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score87
-3 pts
in past quarter
Heat Score 66
1 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Saros Therapeutics

CB Rank
87521
Saros Therapeutics is working to enhance patients' response to immunotherapy.
Founded
obfuscation
PrivateGrant Chicago, Illinois, United States1-10 www.sarostx.com/
Biotechnology
Health Care
Life Science

Funding Rounds

Grant
OBF
in
obfuscation

Key People

Details

Legal Name SAROS THERAPEUTICS INC
Operating Status Active
Company Type For Profit
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Nanoparticle-based Immunotherapy
A nanoparticle designed to target and enhance innate immune pathways, specifically by activating the STING pathway in tumor tissues, macrophages, and dendritic cells.
STING and TLR Agonist Research
Research involving multiple STING agonists and TLR agonists to demonstrate the platform's breadth in enhancing patients' response to immunotherapy.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Saros Therapeutics Logo
Grant - Saros Therapeutics
1
obfuscation
National Cancer InstituteGrant
obfuscation
Grant - Saros Therapeutics Logo
Grant - Saros Therapeutics
1
obfuscation
National Cancer InstituteGrant
obfuscation
Grant - Saros Therapeutics Logo
Grant - Saros Therapeutics
1
obfuscation
National Cancer InstituteGrant
obfuscation
Grant - Saros Therapeutics Logo
Grant - Saros Therapeutics
1
obfuscation
National Cancer InstituteGrant
obfuscation
Grant - Saros Therapeutics Logo
Grant - Saros Therapeutics
1
obfuscation
National Cancer InstituteGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Saros Therapeutics Logo
Grant - Saros Therapeutics
1
obfuscation
National Cancer InstituteGrant
obfuscation
Grant - Saros Therapeutics Logo
Grant - Saros Therapeutics
1
obfuscation
National Cancer InstituteGrant
obfuscation
Grant - Saros Therapeutics Logo
Grant - Saros Therapeutics
1
obfuscation
National Cancer InstituteGrant
obfuscation
Grant - Saros Therapeutics Logo
Grant - Saros Therapeutics
1
obfuscation
National Cancer InstituteGrant
obfuscation
Grant - Saros Therapeutics Logo
Grant - Saros Therapeutics
1
obfuscation
National Cancer InstituteGrant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
National Cancer Institute Logo
National Cancer Institute
Yes
Grant - Saros Therapeutics Logo
Grant - Saros Therapeutics
—
National Cancer Institute Logo
National Cancer Institute
Yes
Grant - Saros Therapeutics Logo
Grant - Saros Therapeutics
—
National Cancer Institute Logo
National Cancer Institute
Yes
Grant - Saros Therapeutics Logo
Grant - Saros Therapeutics
—
National Cancer Institute Logo
National Cancer Institute
Yes
Grant - Saros Therapeutics Logo
Grant - Saros Therapeutics
—
National Cancer Institute Logo
National Cancer Institute
Yes
Grant - Saros Therapeutics Logo
Grant - Saros Therapeutics
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1

Employee Profiles

News

News and Press

News•Sep 25, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

203

IT Spend

$162KThis year, Saros Therapeutics is projected to spend $162K on IT, according to Aberdeen.

Active Website Tech Count

4Saros Therapeutics is actively using 4 technologies for its website, according to BuiltWith. These include Common Crawl, Euro, and  CommonCrawl Top 50m.
Sub-Organizations
Frequently Asked Questions

Where is Saros Therapeutics's headquarters? Saros Therapeutics is located in Chicago, Illinois, United States.Who invested in Saros Therapeutics? Saros Therapeutics is funded by National Cancer Institute.When was the last funding round for Saros Therapeutics? Saros Therapeutics closed its last funding round on
obfuscation
from a Grant round.Who are Saros Therapeutics's competitors? Alternatives and possible competitors to Saros Therapeutics may include Elicio Therapeutics, Agenus, and  Shattuck Labs.How much funding has Saros Therapeutics raised to date? Saros Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(1d83540 1)
|